3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
NETWORK
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
18
Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Uterine Cervical Neoplasms
4
Colorectal Neoplasms
4
Uterine Cervical Dysplasia
3
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Oropharyngeal Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
9
Papillomavirus Vaccines
8
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Surveys and Questionnaires
6
Educational Status
6
Blood Specimen Collection
5
Vaginal Smears
4
Radiotherapy, Intensity-Modulated
4
Methods
4
Human Papillomavirus DNA Tests
4
Early Intervention, Educational
4
Cisplatin
4
Carboplatin
4
Patient Navigation
3
Mass Screening
3
Taxes
2
Standard of Care
2
Radiation
2
Practice Guidelines as Topic
2
Papanicolaou Test
2
Paclitaxel
2
Motivational Interviewing
2
Interviews as Topic
2
Electrocoagulation
2
Docetaxel
2
Cytological Techniques
2
Cryotherapy
2
Colposcopy
2
utomilumab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Papillomavirus Infections
×
Watchful Waiting
×
Clear all
NCT07240220
2026-01-15
Merck-4
Indiana University
Phase NA
Not yet recruiting
2,500 enrolled